These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12460614)

  • 1. Attenuated nuclear shrinkage in neurons with nuclear aggregates--a morphometric study on pontine neurons of Machado-Joseph disease brains.
    Uchihara T; Iwabuchi K; Funata N; Yagishita S
    Exp Neurol; 2002 Nov; 178(1):124-8. PubMed ID: 12460614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated nuclear shrinkage in neurones with nuclear inclusions of SCA1 brains.
    Nagaoka U; Uchihara T; Iwabuchi K; Konno H; Tobita M; Funata N; Yagishita S; Kato T
    J Neurol Neurosurg Psychiatry; 2003 May; 74(5):597-601. PubMed ID: 12700301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influences of intranuclear inclusion on nuclear size - morphometric study on pontine neurons of neuronal intranuclear inclusion disease cases.
    Uchihara T; Tanaka J; Funata N; Arai K; Hattori T
    Acta Neuropathol; 2003 Feb; 105(2):103-8. PubMed ID: 12536220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Onuf's nucleus in Machado-Joseph disease: a morphometric and immunohistochemical study.
    Shimizu H; Yamada M; Toyoshima Y; Ikeuchi T; Onodera O; Takahashi H
    Acta Neuropathol; 2010 Oct; 120(4):439-48. PubMed ID: 20503052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the cerebral cortex and autonomic ganglia in Machado-Joseph disease.
    Yamada M; Hayashi S; Tsuji S; Takahashi H
    Acta Neuropathol; 2001 Feb; 101(2):140-4. PubMed ID: 11271368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging demonstrates differential atrophy of pontine base and tegmentum in Machado-Joseph disease.
    Yoshizawa T; Watanabe M; Frusho K; Shoji S
    J Neurol Sci; 2003 Nov; 215(1-2):45-50. PubMed ID: 14568127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of neuronal intranuclear and cytoplasmic inclusions in Machado-Joseph disease.
    Hayashi M; Kobayashi K; Furuta H
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):205-13. PubMed ID: 12667168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
    Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
    Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease.
    Gonçalves N; Simões AT; Cunha RA; de Almeida LP
    Ann Neurol; 2013 May; 73(5):655-66. PubMed ID: 23625556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain.
    Paulson HL; Das SS; Crino PB; Perez MK; Patel SC; Gotsdiner D; Fischbeck KH; Pittman RN
    Ann Neurol; 1997 Apr; 41(4):453-62. PubMed ID: 9124802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.
    Fujigasaki H; Uchihara T; Koyano S; Iwabuchi K; Yagishita S; Makifuchi T; Nakamura A; Ishida K; Toru S; Hirai S; Ishikawa K; Tanabe T; Mizusawa H
    Exp Neurol; 2000 Oct; 165(2):248-56. PubMed ID: 10993685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products.
    Silva-Fernandes A; Costa Mdo C; Duarte-Silva S; Oliveira P; Botelho CM; Martins L; Mariz JA; Ferreira T; Ribeiro F; Correia-Neves M; Costa C; Maciel P
    Neurobiol Dis; 2010 Oct; 40(1):163-76. PubMed ID: 20510362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional and cellular expression of the Machado-Joseph disease gene in brains of normal and affected individuals.
    Nishiyama K; Murayama S; Goto J; Watanabe M; Hashida H; Katayama S; Nomura Y; Nakamura S; Kanazawa I
    Ann Neurol; 1996 Nov; 40(5):776-81. PubMed ID: 8957019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective occurrence of TDP-43-immunoreactive inclusions in the lower motor neurons in Machado-Joseph disease.
    Tan CF; Yamada M; Toyoshima Y; Yokoseki A; Miki Y; Hoshi Y; Kaneko H; Ikeuchi T; Onodera O; Kakita A; Takahashi H
    Acta Neuropathol; 2009 Oct; 118(4):553-60. PubMed ID: 19526244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease.
    Alves S; Régulier E; Nascimento-Ferreira I; Hassig R; Dufour N; Koeppen A; Carvalho AL; Simões S; de Lima MC; Brouillet E; Gould VC; Déglon N; de Almeida LP
    Hum Mol Genet; 2008 Jul; 17(14):2071-83. PubMed ID: 18385100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
    Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
    Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brainstem in Machado-Joseph disease: atrophy or small size?
    Horimoto Y; Matsumoto M; Yuasa H; Kojima A; Nokura K; Katada E; Yamamoto T; Yamamoto H; Mitake S
    Eur J Neurol; 2008 Jan; 15(1):102-5. PubMed ID: 18042234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectoine alters subcellular localization of inclusions and reduces apoptotic cell death induced by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch.
    Furusho K; Yoshizawa T; Shoji S
    Neurobiol Dis; 2005 Oct; 20(1):170-8. PubMed ID: 16137577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal study on MRI intensity changes of Machado-Joseph disease: correlation between MRI findings and neuropathological changes.
    Horimoto Y; Matsumoto M; Akatsu H; Kojima A; Yoshida M; Nokura K; Yuasa H; Katada E; Yamamoto T; Kosaka K; Hashizume Y; Yamamoto H; Mitake S
    J Neurol; 2011 Sep; 258(9):1657-64. PubMed ID: 21416210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Full-length expanded ataxin-3 enhances mitochondrial-mediated cell death and decreases Bcl-2 expression in human neuroblastoma cells.
    Tsai HF; Tsai HJ; Hsieh M
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1274-82. PubMed ID: 15504352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.